Research progress on dose-effect-toxicity relationship of EGFR- and ALK-tyrosine kinase inhibitors in the treatment of non-small cell lung cancer

Pei Yihan, Li Yue, Bi Yunyan, Guo Nan, Zhang Wen

PDF(386 KB)
PDF(386 KB)
Adverse Drug Reactions Journal ›› 2024, Vol. 26 ›› Issue (3) : 178-183. DOI: 10.3760/cma.j.cn114015-20231129-00845

Research progress on dose-effect-toxicity relationship of EGFR- and ALK-tyrosine kinase inhibitors in the treatment of non-small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 26(3): 178-183 https://doi.org/10.3760/cma.j.cn114015-20231129-00845

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(386 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉